Ming You mostly deals with Lung cancer, Carcinogenesis, Gene, Molecular biology and Cancer research. The study incorporates disciplines such as Lung cancer susceptibility, Cancer, Genetics and Gene expression profiling in addition to Lung cancer. His biological study spans a wide range of topics, including Bioinformatics and Adenocarcinoma.
The concepts of his Carcinogenesis study are interwoven with issues in Immunology, Ratón, Mutant and Pathology. Ming You combines subjects such as Cell culture and Lung with his study of Molecular biology. Ming You has researched Cancer research in several fields, including Tumor progression, Kinase, Gene knockdown and Cell growth.
His primary areas of investigation include Cancer research, Lung cancer, Carcinogenesis, Cancer and Gene. His Cancer research study integrates concerns from other disciplines, such as Cell, Cell cycle, Apoptosis, Cell growth and Tumor progression. His Lung cancer research entails a greater understanding of Internal medicine.
The various areas that he examines in his Carcinogenesis study include Pathology, Genetically modified mouse, Immunology and Carcinogen. His study in Cancer is interdisciplinary in nature, drawing from both Disease and Genetic epidemiology. Gene is a subfield of Genetics that Ming You tackles.
Ming You spends much of his time researching Lung cancer, Cancer, Cancer research, Genetics and Internal medicine. His Lung cancer research includes elements of Cell growth, Lung, Disease, PI3K/AKT/mTOR pathway and Adenocarcinoma. While the research belongs to areas of PI3K/AKT/mTOR pathway, Ming You spends his time largely on the problem of Field cancerization, intersecting his research to questions surrounding Oncogene, Receptor and Gene expression.
His work carried out in the field of Cancer brings together such families of science as Clinical trial, Immunology and Traditional medicine. His Cancer research research is multidisciplinary, incorporating perspectives in Honokiol, Cancer cell, Immune system, KRAS and Metastasis. His work in Internal medicine addresses issues such as Oncology, which are connected to fields such as Chemotherapy.
Ming You mainly investigates Lung cancer, Cancer, Cancer research, Genetics and Disease. His Lung cancer research is multidisciplinary, relying on both Immunology, Cell growth, DNA repair and Pharmacology. His work on Cell growth is being expanded to include thematically relevant topics such as Molecular biology.
His Cancer research focuses on Carcinogenesis, Brain metastasis, Metastasis and Cancer prevention. His work in Cancer prevention covers topics such as KRAS which are related to areas like Adenocarcinoma. His Cancer research research incorporates elements of Honokiol, Cancer cell, STAT3, PI3K/AKT/mTOR pathway and Programmed cell death.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
Ken Inoki;Hongjiao Ouyang;Tianqing Zhu;Charlotta Lindvall.
Cell (2006)
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Ramaswamy Govindan;Li Ding;Malachi Griffith;Janakiraman Subramanian.
Cell (2012)
Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse
Ming You;Urs Candrian;Robert R. Maronpot;Gary D. Stoner.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Principles for the post-GWAS functional characterization of cancer risk loci
Matthew L Freedman;Alvaro N A Monteiro;Simon A Gayther;Simon A Gayther;Gerhard A Coetzee.
Nature Genetics (2011)
A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25
J. E. Bailey-Wilson;C. I. Amos;S. M. Pinney;G. M. Petersen.
American Journal of Human Genetics (2004)
Wildtype Kras2 can inhibit lung carcinogenesis in mice.
Zhongqiu Zhang;Yian Wang;Haris G. Vikis;Leisa Johnson.
Nature Genetics (2001)
A gene expression signature predicts survival of patients with stage I non-small cell lung cancer
Yan Lu;William Lemon;Peng Yuan Liu;Yijun Yi.
PLOS Medicine (2006)
Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with Rheb
Yong Li;Yian Wang;Eunjung Kim;Peter Beemiller.
Journal of Biological Chemistry (2007)
Patterns and functional implications of rare germline variants across 12 cancer types
Charles Lu;Mingchao Xie;Michael C. Wendl;Jiayin Wang;Jiayin Wang.
Nature Communications (2015)
Tumor Susceptibility of Rassf1a Knockout Mice
Stella Tommasi;Reinhard Dammann;Zhongqiu Zhang;Yian Wang.
Cancer Research (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
Baylor College of Medicine
Mayo Clinic
National Institutes of Health
Wayne State University
Mayo Clinic
The Ohio State University
University of Colorado Denver
National Institutes of Health
National Institutes of Health
Virginia Tech
Acteurs, Ressources et Territoires dans le Développement
University of Cagliari
University of Tokyo
University of Liverpool
Memorial University of Newfoundland
MIT
University of Aberdeen
University of California, Irvine
University of Auckland
University of Maryland, Baltimore
Children's Hospital of Philadelphia
University of California, Los Angeles
Ludwig-Maximilians-Universität München
George Washington University
MIT